December 18, 2014 - Dr. Mark Cushman awarded a new U.S. patent

December 18, 2014 - Dr. Mark Cushman, Distinguished Professor of Medicinal Chemistry, has been awarded a new U.S. patent entitled “Synthesis and use of dual tyrosyl-DNA phosphodiesterase I (TDP1) - topoisomerase I (TOP 1) inhibitors”. This patent is for novel compounds that demonstrate anticancer activity.

Mega Menu Visual Content